Allergan (United States)

Allergan (United States)

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Allergan (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

45%


Total
Publications

2.5K


Total Open
Publications

1.1K


Total
Citations

112K


Open Access
Percentage

45%


Total
Publications

2.5K


Total Open
Publications

1.1K


Total
Citations

112K

Wikipedia

Website

download

Breakdown

21% 22% 3% 54%

Publisher Open

21%

Both

22%

Other Platform Open

3%

Closed

54%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

436

Hybrid 42%

452

No Guarantees 18%

192

Other Platform Open

Domain 77%

488

Other Internet 22%

136

Institution 16%

104

Public 3%

17

Preprint 0%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
488
DOI
Other Internet
100
Europe PMC
Domain
59
Unknown Repository
Other Internet
45
Figshare
Public
12
Washington University School of Medicine - Digital Commons@Becker
Institution
11
DASH - Digital Access to Scholarship at Harvard
Institution
9
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
7
University of Melbourne - Minerva Access
Institution
6
DANS - Data Archiving and Networked Services
Institution
6
1 / 9

Data updated 18 August 2025

Share

Share

Share